Skip to main content
. 2023 Feb 13;37:103349. doi: 10.1016/j.nicl.2023.103349

Table 1.

Characteristics of the study participants.

MS
(n = 119)
MS-GMcLs
(n = 85)
RRMS
(n = 64)
SPMS
(n = 34)
PPMS
(n = 21)
HC (n = 98)
Age[mean (SD)
, years]
48.3
(13.9)
51.2
(12.9)
39.6
(11.2)
56.7
(9.0)
60.8
(9.5)
36.8 (12.5)
Sex
[male/female, n]
47/72 36/49 19/45 15/19 13/8 43/55
Disease duration [mean (SD), months] 11.79 (15.1) 12.16 (12.8) 5.5
(6.5)
20.9
(13.5)
16.3
(25.2)
Lesions count [mean (SD), n] 50.8
(39.3)
10.9
(15.1)
45.3
(40.8)
52.4
(24.4)
65.0
(50.5)
Lesions volume [median (range),mm3] 6795.0 (105.0–66664.0) 134.0 (1956.0-
8.0)
2902.0 (105.0–45410.0) 12224.0 (2186.0–66664.0) 10851.0
(764.0–48258.0)
EDSS[median (range)
, n]
3.0
(1.5–7.5)
3.5
(1.5–7.5)
2.0
(1.5–7.0)
6.0
(2.0–7.5)
4.0
(2.0–6.5)